Internal Medicine, Hematology & Oncology · San Juan, PR
NPI
1295713337
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
576 Calle Cesar Gonzalez Ste 503
San Juan, PR, 00918
Phone (787) 766-2083
Medicare paid, 2024
$181K
18,784 services
Medicare patients, 2024
135
Average age 78
Drug cost, 2024
$8.7M
2,329 prescriptions
Company payments, 2025
$21K
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jose A Lozada Costas was code 99215 (office e&m - established), 284 times for 105 patients. In total Jose A Lozada Costas billed 18,784 services in 44 codes, and Medicare paid $181K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 284 | 105 | $137.15 | $39K |
| 99214 Office E&M - Established | Office | 162 | 82 | $72.88 | $12K |
| 96401 Chemotherapy Administration | Office | 119 | 21 | $53.05 | $6,313 |
| 96367 Intravenous Infusion, Hydration | Office | 27 | 12 | $21.21 | $573 |
By year: 2022 $492K for 21,441 services; 2023 $379K for 21,201 services; 2024 $181K for 18,784 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jose A Lozada Costas prescribed most often to Medicare patients was Anastrozole, with 596 prescriptions and refills. In total Jose A Lozada Costas wrote 2,329 Medicare prescriptions that cost $8.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 596 | 792 | 96 | $10K |
| Raloxifene Hcl Generic | 203 | 273 | 40 | $9,994 |
| Xtandi Enzalutamide | 199 | 199 | 23 | $2.8M |
| Exemestane Generic | 136 | 168 | 25 | $12K |
| Hydroxyurea Generic | 88 | 98 | 13 | $3,245 |
| Dexamethasone Generic | 74 | 74 | 15 | $1,198 |
| Prednisone Generic | 64 | 68 | 17 | $385 |
| Ondansetron Odt Ondansetron | 62 | 62 | 28 | $942 |
| Tamoxifen Citrate Generic | 61 | 83 | 11 | $1,766 |
| Abiraterone Acetate Generic | 57 | 57 | Under 11 | $66K |
| Ibrance Palbociclib | 54 | 58 | Under 11 | $921K |
| Revlimid Lenalidomide | 52 | 52 | Under 11 | $1.0M |
| Imbruvica Ibrutinib | 36 | 36 | Under 11 | $600K |
| Jakafi Ruxolitinib Phosphate | 36 | 36 | Under 11 | $618K |
| Xarelto Rivaroxaban | 36 | 48 | Under 11 | $27K |
Brand drugs: 736 claims; generic drugs: 1,593 claims; opioid claims: 48.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jose A Lozada Costas $21K ($21K in general payments such as food, travel and fees) from 34 companies. The largest payer was Abbvie Inc. with $8,731.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $8,731 |
| E.R. Squibb & Sons, L.L.C. BMY | 39 | $3,924 |
| Merck Sharp & Dohme LLC MRK | 18 | $1,873 |
| Pfizer Inc. PFE | 3 | $1,675 |
| Amgen Inc. AMGN | 9 | $1,002 |
| AstraZeneca Pharmaceuticals LP AZN | 26 | $717 |
| Pbg Puerto Rico LLC | 25 | $586 |
| Janssen Pharmaceuticals, Inc JNJ | 25 | $579 |
| Novartis Pharmaceuticals Corporation NVS | 16 | $389 |
| Genentech USA, Inc. ROG.SW | 8 | $187 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.